Side-by-side financials for ENVB and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ENVB | NVS |
|---|---|---|
| Market cap | - | $282.64 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $39.91M | - |
| Net income (latest FY) | $12.10M | - |
| Net margin | 30.3% | - |
| SEC filings | 1,004 | 947 |
Full pages: Enveric Biosciences, Inc. and Novartis AG, or browse the full rankings.